The relationship between cerebrospinal fluid (CSF) markers of HIV infection and the
spectrum of neurological manifestations were studied in 15 AIDS patients (13 with and 2 …

In up to 50% of all human immunodeficiency virus (HIV) patients, the nervous system is
clinically involved. Primary or secondary manifestations of the nervous system have been …

The human immunodeficiency virus (HIV) can cause neurological symptoms. It is not known
how the the cerebrospinal fluid (CSF) may change during the infection. Thirty‐eight …

Intrathecal antibody responses to HIV were investigated by a highly sensitive immunoblot
assay. Serum and CSF specimens were tested for reactivity with the recombinant HIV gag …

Isolation of the human immunodeficiency virus (HIV) has been attempted from the
cerebrospinal fluid (CSF) of 29 subjects with varying severity of HIV infection. Virus could be …

We analysed 127 specimens of cerebrospinal fluid (CSF) from 118 HIV-1-infected
individuals at different stages of infection. Intrathecal antibody synthesis was evident in 23 …

The reactivities of intrathecal and serum IgG and IgM, and IgG1–4 subclass antibodies to
various HIV-1 proteins were assessed by immunoblotting at various stages of HIV-1 …

Attempts to isolate human immunodeficiency virus type 1 (HIV‐1) were carried out on
cerebrospinal fluid (CSF) and blood plasma samples from 111 HIV‐1 infected subjects in …

We evaluated prospectively the HIV-1 RNA level in CSF as a marker of HIV encephalitis
diagnosis. 110 HIV-1 infected patients (mean age: 39 years; sex-ratio M/F: 94/16) were …

Cerebrospinal fluid (CSF) analytes were evaluated in 59 human immunodeficiency virus
(HIV+) individuals to assess neurological involvement. Glucose, total protein, cell counts …